Table 1 Demographic, anthropometric, clinical characteristics of patients.

Male _{n (%)}

10 (45.45)

17 (72.27)

0.03

Age _(years)

64 ± 6.9

68 ± 8.9

0.14

Weight _(kg)

61.7 ± 15.3

71.7 ± 17.4

0.06

Height _(cm)

163 ± 0.09

166 ± 0.10

0.12

BMI _(kg/m²)

23.1 ± 4.7

25.7 ± 6.1

0.08

Pulmonary Function

FEV_1(L)

1.26 ± 0.4

1.40 ± 0.7

0.72

FEV_1%pred.

52.7 ± 17.5

54.8 ± 16.7

0.55

FVC _(L)

2.6 ± 0.7

2.7 ± 0.8

0.61

FVC _%pred.

87.7 ± 17.9

79.4 ± 24.6

0.16

FEV₁/FVC

0.49 ± 0.10

0.51 ± 0.13

0.38

Polysomnographic

AIH _(/h)

3.4 ± 1.2

16.9 ± 14.9

< 0.0001

ODI _(/h)

6.7 ± 3.4

21.9 ± 10.9

< 0.0001

SpO₂ media _(%)

89.4 ± 2.6

87.6 ± 3.2

0.40

SpO₂ < 90% _{(%total sleep)}

58.4 ± 29.7

78.6 ± 19.8

0.02

Severity OSAS _{% (Mild/Moderate/Severe)}

-

(54,5/36,4/9,1)

-

Medications

SABA _{n (%)}

16 (72.7)

15 (61.2)

0.75

LABA _{n (%)}

11 (50)

9 (40.9)

0.56

LAMA _{n (%)}

4 (18.2)

7 (31.2)

0.31

IC _{n (%)}

11 (50)

10 (45.5)

0.96

Antihypertensive _{n (%)}

4 (18.2)

4 (18.2)

0.99

Level of physical activity

Baecke Questionnaire

2.9 ± 2.2

2.2 ± 1.5

0.32